Accenture CEO Julie Sweet’s cancer diagnosis shows how execs should share life-altering health events
Diane Brady on how CEOs should handle a cancer diagnosis. The big story: Reciprocal trade tariffs. The markets: Approaching ...
Accenture CEO Julie Sweet diagnosed with early-stage breast cancer, treatment likely to last 12-16 weeks
Nonetheless, the CEO of the world’s largest IT company will lead its day-to-day operations throughout the process.
Accenture CEO Julie Sweet diagnosed with cancer, to undergo surgery next week
Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer. With an excellent prognosis and a curable ...
Meet CEO of one of world's biggest IT firms, who will undergo treatment for breast cancer
Julie Sweet, Chief Executive Officer of Accenture has recently been diagnosed with early-stage breast cancer and will undergo ...
Yahoo News UK5d
Accenture CEO’s Cancer Diagnosis Gives Insight Into How Execs Divulge Illness
Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare insight into how executives disclose their life-altering health news. Sweet, ...
AOL5d
Accenture CEO Julie Sweet’s cancer diagnosis shows how execs should share life-altering health events
Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the prognosis from my doctor is excellent; the cancer was caught ...
Business Today4d
Accenture CEO diagnosed with breast cancer, to undergo surgery next week
Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer and the treatment is likely to last 12-16 weeks, according to a Moneycontrol report. However, the CEO will continue to ...
Fortune5d
Accenture CEO Julie Sweet’s cancer diagnosis shows how execs should share life-altering health events
CEO of Accenture Julie Sweet. © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy ...